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ABSTRACT
￿
The shape change and aggregation of washed platelets induced by 10 AM arachi-
donic acid (AA) can be reversed by 20 ng/ml prostacyclin (PGI2), but these platelets can be
reactivated by treatment with 30 AM epinephrine and subsequent addition of 10 AM AA
mixture. These events may be modulated by CAMP since 2 mM dibutyryl CAMP also reversed
activation without reactivation by epinephrine and AA. We examined protein phosphorylation
and formation of cytoskeletal cores resistant to 1 % Triton X-100 extraction of these platelets
and correlated these processes with aggregation, fibrinogen binding, and changes in ultrastruc-
ture. Unactivated platelet cores contained <15% of the total actin and no detectable myosin
or actin-binding protein. AA-induced cytoskeletal cores, which contained 60-80% of the total
actin, myosin, and actin-binding protein as the major components, were disassembled back
to unactivated levels by PGI2 and then fully reassembled by epinephrine and AA. Phospho-
rylation of myosin light chain and a 40,000-dalton protein triggered by AA (two- to fivefold)
was reversed to basal levels by PG1 2 but was completely restored to peak levels upon addition
of the epinephrine and AA mixture. The reversibility of actin-binding protein phosphorylation
could not be established clearly because both PGI2 and dibutyryl CAMP caused its phospho-
rylation independent of activation . With this possible exception, cytoskeletal assembly with
associated protein phosphorylation, aggregation, fibrinogen binding, and changes in ultrastruc-
ture triggered by activation are readily and concertedly recyclable.
That platelet activation with all of its structural rearrange-
ments basically reflects the activity of cytoskeletal processes
has long been recognized (1). Our previous studies have
demonstrated a de novo cytoskeletal assembly process upon
platelet activation. One of the initial steps in this process is
extensive actin polymerization from a large pool of mono-
mericactin present in the resting platelet. These newly formed
actin filaments interact with actin-binding protein (ABP)' to
form pseudopodal projections and with myosin to form a
contractile microfilament network responsible for centraliza-
tion of secretory granules (2). The contractile activity of this
actomyosin has been shown to be regulated through phospho-
rylation of the 20,000-dalton light chains of myosin (MLC)
'Abbreviations usedin thispaper:
￿
AA, arachidonic acid; ABP, actin-
binding protein; MLC, light chains of myosin; 40P, 24P, and 22P:
40,000-, 24,000-, and 22,000-dalton polypeptide, respectively; PG12,
prostacyclin.
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by myosin kinase (3, 4). Calcium flux either through the
plasma membrane or from the dense tubular system (5)
regulates this myosin kinase through its interaction with cal-
modulin (6).
In addition to MLC, ABP (7) and a 40,000-dalton protein
(8) (40P)z are phosphorylated during platelet activation. MLC
has <0.1 mol phosphate/mol protein before activation and
>0.9 mol phosphate afteractivation (4). The phosphorylation
of40P, estimated after isolation from activated platelets, is in
excess of 0.5 mol of phosphate/mol protein (9). Based on the
stoichiometry of MLC phosphorylation and the pool sizes of
these proteins, calculations suggest that phosphorylation of
actin-binding protein approaches 1 mol phosphate/mol mon-
omer after activation (7). Unlike the case with MLC activa-
2 This protein actually has a molecular mass of47,000 daltons (9) but
electrophoresis anomalously as a 40,000-dalton protein in the gel
system used in this study.
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during platelet stimulation have not been established.
In addition to the internal processes discussed above, plate-
let cytoskeletal assembly has been shown to have specific
interactions with plasma membrane proteins. Amongst these
interacting membrane proteins is the glycoprotein IIb-III com-
plex shown by Phillips et al. (10) to mediate platelet aggrega-
tion. This complex was subsequently identified as the binding
site for fibrinogen (11) known to be involved in platelet
aggregation (12).
Platelets in plasma, once activated and aggregated, can be
redispersed by addition of prostacyclin (PGI2) and then sub-
segeuently reactivated by a combination of arachidonic acid
(AA) and epinephrine (13). Epinephrine, which reduces the
cAMP levels induced by PGI2, resensitizes the platelets to AA.
Platelets redispersed by PGI2 regain their unactivated ultra-
structure, and the reaggregation occurs normally. In this
study, we examined the reversibility of cytoskeletal assembly
and actin polymerization during the cyclic activation of
washed platelets and correlated these processes with changes
in ultrastructure, platelet aggregation, fibrinogen binding, and
protein phosphorylation.
MATERIALS AND METHODS
Platelet Preparation and Labeling with ["P]Orthophos-
phate:
￿
Platelets were isolated from citrate anticoagulated whole blood, as
has been described previously (2), and suspended at 1 x 10' platelets/ml in
Tangen-HEPES-BSA buffer (145 mM sodium chloride, 5 mM potassium
chloride, 0.1 mM magnesium chloride, 0.05 mM calcium chloride, 5.5 mM
glucose, I mg/ml BSA, and 15 mM HEPES, pH 7.4). The platelets were allowed
to incorporate ["P]orthophosphate (1 mCi/ml) for 45 min at 37°C. Residual
plasma protein and unincorporated "P-label were then removedby gel filtering
at 4°C on a Sepharose 2B column equilibrated andeluted with Tangen-HEPES-
BSA buffer. The bed volume of the column was 10 times the applied sample
volume. The plateletswere collected, counted, and adjusted to 5 x 108 platelets/
ml with buffer. After 30-min incubation at 37°C the platelets recovered their
discoid shape as detected by light microscopy.
Aggregation and Reagents:
￿
Aggregation was monitored in a Day-
ton dual channel aggregometer (Dayton Associates, Buffalo, NY) thermostated
at 37°C. Platelet samples of 1-5 ml were treated as indicated in the figure
legends with 10 AM AA (NuChek Prep, Elysian, MN) added from a 1-mM
solution, 20 ng/mI PGIZ from a 10,ug/ml-stock solution, 30 pM epinephrine
(Sigma Chemical Co., St. Louis, MO) from a l-mM stock solution, 2 mM
dibutyryl cAMP (Sigma Chemical Co.) from a 100-mM solution, or 10 AM
phorbol 13-myristate 12-acetate (DMA from P-L Biochemicals, Inc., Milwau-
kee, WS) from a l-mM stock solution. Dibutyryl CAMP solutions were freshly
made for each experiment. PMA in dimethylsulfoxide was stored at -20°C
while PG1Z solutions, adjusted to pH 9, were stored at -70°C for not more than
a 4-wk period.
Fibrinogen Binding: Human fibrinogen (Type L, Kabi Group,
Greenwich, CT) was treated with diisopropylfluorophosphate (l2). This solu-
tion was either dialyzed into 150 mM NaCl, 20 mM HEPES, pH 7.4 for a
stock solution ordialyzed into 100 mM sodium borate, pH 8.5 for radiolabeling
by the method of Bolton and Hunter (14). After labeling, this fibrinogen was
also dialyzed into the same buffer as the stock solution. Fig. I shows a
densitometric tracing of the autoradiogram of SDS PAGE gel of reduced
fibrinogen. The labeled fibrinogen was denatured in 2% SDS, containing 2%
2-mercaptoethanol, and electrophoresed according to the procedure ofStudier
(15). The three closely spaced peaks arise from theA-alpha, B-beta, and gamma
polypeptides of fibrinogen, and the high molecular weight contaminant is
probably plasma fibronectin which contained 10% of the total radioactivity
found in the fibrinogen polypeptides. 92% ofthe label was coagulable. Concen-
trations of fibrinogen were calculated using a value of 15.1 (16) for Al%_, 280
nm.
Fibrinogen binding was measured using the technique described for coagu-
lation Factor Xa (17). Aliquots (0.2 ml) ofplatelet suspension containing the
[izsl]fibrinogen were layered onto a mixture of one part Apiezon oil (Biddle
Instruments, Blue Bell, PA) and nine parts n-butylphthalate. The sample was
immediately centrifuged at 10,000 g for 3 min. An aliquot ofthe supernatant
was counted to determine the concentration of unbound fibrinogen, and the
pellet was counted to determine the amount bound.
Preparation of Cytoskeletal Cores:
￿
Cytoskeletal cores were iso-
lated from unlabeled platelets by centrifugation at 11,000 g for 5 min after
extraction with I % Triton X-100, 50 mM Tris-HCI, 5 mM EGTA, pH 7.4 as
described by Phillips et al. (10). To facilitate comparisons, all samples applied
to the SDS PAGE gels were obtained from the same number of platelets.
Therefore, the sum of protein at any molecular weight region of the gel from
the cytoskeletal core and supernatant lanes would equal the protein in that
same region from a whole platelet lane. To accomplish this, the following
procedure was adopted. A denaturation bufferwas prepared that contained 2%
SDS, 2% 2-mercaptoethanol, 10% glycerol, 1 mM EDTA, 4 mM EGTA, 0.01 %
bromophenol blue, 150 mM Tris-HCI, pH 6.8 and another denaturation buffer
at five times the concentrations ofeach ingredient. A 0.2-ml aliquot ofa platelet
sample was mixed with 0.2 ml of extraction buffer and the cores collected. A
0.2-ml aliquot ofthe supernatant was denatured with 0.04 ml of the fivefold
concentrated denaturation buffer. After thoroughly removing the remaining
supernatant, the cytoskeletal-core pellets were denatured in a volume of dena-
turation buffer equal to the original platelet volume. A 0.1-ml aliquot of the
denatured supernatant and a 0.04-ml aliquot of the cytoskeletal core fraction,
both equivalent to 0.04 ml of the original platelet suspension, were electropho-
resedon 6-17.5% polyacrylamide gradientgels preparedas described by Studier
(15), then fix-stained with Coomassie Blue, destained, and scanned on a LKB
Ultrascan Laser Densitometer to quantify protein bands.
DNAase 1 Assay For Monomeric Actin:
￿
Total actin content in
cytoskeletal core and supernatant fractions and in whole platelet lysates after
depolymerization for 30 min at 0°C in 0.75 M guanidine-HCI, 0.5 M sodium
acetate, 0.5 mM sodium-ATP, 10 mM Tris-HCI, 0.5 mM calcium chloride, pH
7.5 was measured by a DNAase-l-inhibition assay originally described by
Blikstad et al. (18) and applied to platelets(19) but slightly modifiedby Carroll
et al. (2).
The monomeric actin content in unfractionated platelet lysates was mea-
sured within 3 min after adding the extraction buffer containing Triton X-100
plus EGTA. Monomeric actin contents are expressed as a percentage of the
total platelet actin content determined as described above. The validity ofthese
assays for total and monomeric actin in platelets was established previously
(19).
Phosphorylation ofPlatelet Proteins:
￿
Phosphorylationofplatelet
ABP, 20,000-dalton MLC, 40P, 24,000-dalton peptide (24P), and 22,000-dalton
peptide (22P) was determined during the course of activation, reversal, and
reactivation. Aliquots (0.05 ml) were taken at the indicated times and imme-
diately denatured by heating for 3 min at 100°C after adding 0.025 ml of a
threefold concentrated denaturation buffer (see above). These samples were
stored at -20°C and reheated for 2 min at 100°C before electrophoresis as
described above. The gels weresoaked for 30min at 60°C in 10% trichloroacetic
acid before fix-staining, destaining, drying, autoradiographing, and quantifying
"P-CPM/gel band as previously described (7). Molecular weights of phospho-
rylated bands were determined by co-electrophoresis of platelet actin-binding
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FIGURE 1
￿
SDS PAGE of ['"]fibrinogen. The radiolabeling of the
human fibrinogen and the electrophoresis of the reduced, dena-
tured product was performed as described in Materials and Meth-
ods. The autoradiogram was obtained from the dried gel that was
exposed for 1 d to Kodak BB-5 x-ray film. Thedensitometer tracing
wasobtained usingan LKB laser densitometer. The arrow indicates
the beginningof the gradient gel.
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Cyclic Cytoskeletal Assemblyprotein (250,000 daltons), myosin (200,000 daltons heavy chains, 20,000- and
16,000-dalton light chains), andactin (43,000 daltons) isolated as previously
described (7) as well as standard proteins obtained from Bio-Rad Laboratories
(Richmond, CA) consisting of myosin (200,000-dalton heavy chain), beta-
galactosidase(116,000 daltons), phosphorylaseB(94,000daltons), BSA(68,000
daltons), ovalbumin (43,000 daltons), carbonic anhydrase (30,000 daltons),
soybean trypsin inhibitor (21,000 daltons), andlysozyme (14,300 daltons). In
addition, bovine pancreas alpha-chymotrypsinogen (23,500 daltons, from
Worthington Biochemical Corp., Freehold, NJ) was utilized as a molecular
weight marker for the 24Pband.
Ultrastructure:
￿
Samples ofplatelets during the course of the recycling
activation were fixed for examination in the electron microscope according to
methodsreported in detail inprevious publications(20-22). Briefly, the samples
werecombined with an equal volume of0.1 %glutaraldehyde in White'ssaline,
pH 7.3. After IS min at 37°C, the fixed platelets were centrifuged into pellets
and the supernatant wasreplaced with 3% glutaraldehyde in the same buffer.
Fixation was continued at 4°C for60 min. Thecells were then washed in buffer
and further fixed with 1% osmium tetroxide in veronal acetate buffer. After
exposure to the second fixation for 60 min, the samples were dehydrated in a
graded series of alcohol andembedded in Epon 812. Contrast of thin sections
cut from plastic blockson an ultramicrotome was enhancedwithuranyl acetate
and lead citrate. Observations were made in a Philips 301 electron microscope.
RESULTS
Electron Microscopy-Aggregometry
The platelets used in these studies were concentrated by
centrifugation and further washed by gel filtration. They
maintained most oftheir discoid form, but some platelets had
short pseudopod projections. Thin sections as shown in Fig.
2A revealed the lentiform shape supported by circumferential
microtubule bundles. Mitochondria as well as secretory alpha-
granules and dense bodies were randomly dispersed in the
cytoplasm, which also contained discrete particles and large
masses of glycogen.
Addition of 10 AM AA to platelets with constant stirring
led to extensive aggregation as shown in Fig. 3. Examination
by electron microscopy ofa sample withdrawn just before the
indicated addition ofPGI2 revealed changes typical ofplatelets
exposed to potent activators (Fig. 2 B). The cells lost their
discoid form and became irregular with many intertwining
pseudopods in large platelet aggregates. The platelet profiles
in which alpha-granules and dense bodies were visible showed
a concentration ofthose granules in the centers of most cells.
Many of these centralized granules were seen to be encircled
by close-fitting rings of microtubules and microfilaments (as
indicated by arrowheads).
The platelet aggregates induced by AA couldbe dissociated
by the addition of PGI2 (Fig. 3). Samples prepared for electron
microscopy afterthe return of the aggregometry tracings to a
plateau close to the control platelet baseline showed complete
disaggregation of the cells (Fig. 2 C). Most of these cells had
recovered a discoid form, and only occasional short pseudo-
podal projections were observed. Indeed, the general appear-
ance ofthe PGI2-treated cells was somewhat more regular and
discoid than the untreated control platelet. Bundles of micro-
tubules could again be observed at the polar ends of cross-
sectioned cells, supporting the lentiform shape. The granules,
although fewer in number, had also returned to a randomly
dispersed pattern.
The platelets, after disaggregation induced by PGI2, were
reactivated by a combination ofepinephrine plus arachidonic
acid. The platelets again underwent a full aggregation response
(Fig. 3) and when fixed for electron microscopy revealed a
return to the activated state with pseudopodal development
and granule centralization (Fig. 2 D).
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Fibrinogen Binding
Since aggregation by AA as well as ADP has been shown
to be mediated by fibrinogen binding to the platelets, we
examined the expression of fibrinogen-binding site as a func-
tion of activation-reversal-reactivation . The experimental
conditions were identical to those used in Fig. 2, except that
0.69 AM human fibrinogen was added to the gel-filtered
platelets 10 min before activation with AA. Sample aliquots
were taken before activation, at a point about halfway up the
aggregation curve during the initial aggregation, during the
plateau in the disaggregation response after PGI2 addition,
and at the plateau of reaggregation by epinephrine and AA.
Binding was measured at two separate radiospecific activities
obtained by mixing the labeled fibrinogen with unlabeled
fibrinogen. No difference in the amount of fibrinogen bound
was detected over a threefold difference in radiospecific activ-
ity, indicating that the labeled and unlabeled fibrinogen were
binding similarly and the nonspecific binding was within the
experimental error of the binding assay. The amount of
radioactivity in the platelet pellet was corrected for a trapped
volume of 0.23 Al per 108 platelets (23). The results of these
binding studies are listed in Table I. Although a sample was
taken at the peak of the first aggregation, binding could not
be determined, since large, loose aggregates were present that
would not penetrate the butylphthalate layer. However, the
results clearly demonstrate the cyclic binding of fibrinogen
that occurred during the cycles of aggregation and deaggre-
gation.
Cytoskeletal Cores and Actin Polymerization
Previous studies have supported a role for the polymeriza-
tion of actin and its interaction with myosin and actin-binding
protein in platelet activation. These processes have been fol-
lowed by isolation ofcytoskeletal cores resistant to 1 % Triton
X-100 extraction and by quantifying both monomeric and
total actin content in platelet whole lysate as well as core and
supernatant fractions (2).
Fig. 4 shows the protein composition of the typical cyto-
skeletal core developed during 10 AM AA activation (lane 3)
and the loss of these proteins when the core was completely
disassembled by PG12 treatment (lane S) and the return to the
original protein composition as the core was reassembled after
addition ofepinephrine plus AA (lane 7). A similar cycling of
actin polymerization was detected in whole platelet lysates by
the DNase I assay as shown in Table II. The sampling of the
platelets during the time course corresponded exactly to those
taken for the electron microscopy study, and both studies
were performed on the same preparation ofplatelets.
Table II also shows the total content of actin following
guanidine depolymerization of multimeric actin in superna-
tant and pelleted cytoskeletal core fractions prepared from
aliquots taken at the same time as samples denatured for SDS
PAGE (gel shown in Fig. 4). The small amount ofcytoskeletal
core found in control platelets and the 60-80% of actin,
myosin, and ABP incorporated into cytoskeletal core ofacti-
vated platelets were similar to the values previously reported
for control platelets and those fully activated by thrombin (2).
The drop in monomeric actin as a percentage of the total
platelet actin from 68 ± 4% to 25 ± 6% was also similar to
that observed for fully activated platelets (2). The increase of
monomeric actin content to near control levels by PGI2FIGURE 2
￿
Platelet ultrastructure during cyclic activation . The preparation of the samples is described in Materials and Methods .
The electron micrographs are of the following samples : (A) unactivated washed platelets, (B) platelets at maximum aggregation
after addition of 10,uM arachidonic acid, (C) platelets disaggregated by addition of 20 ng/ml PG12, and (D) platelets reaggregated
by addition of 30 jAM epinephrine and 10 AM arachidonic acid . Cellular features identified in the figures are microtubules
(arrowheads), dense bodies (DB), alpha-granules (G), mitochondria (M), and glycogen particles (Gly) . Bar, 1 wm (A) . x 9,600 .
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FIGURE 3
￿
Platelet aggregation during cyclic activation . The aggre-
gometer tracing of a suspension of washed platelets indicates the
course of aggregation during activation with 10 1AM arachidonic
acid (AA), reversal of activation by addition of 20 ng/ml PGIZ and
resensitization by addition of 30 pM epinephrine (E), and reactiva-
tion by a second addition of arachidonic acid . The arrows indicate
time of additions .
TABLE I
Fibrinogen Binding during Cyclic Activation of Platelets
Platelet sample
￿
Molecules/Platelet*
" Average of the number of fibrinogen molecules bound per platelet calcu-
lated from two separate experiments .
= The average number calculated at about halfway through the maximum
aggregation response .
reversal ofAA activation indicated that the actin polymeri-
zation process was also reversible .
Phosphorylation of Platelet Protein
Platelet activation has been shown to be accompanied by
two- to fivefold increases in '2P-labeling of ABP, 20,000-
dalton MLC, as well as the 40P (7-9) ofunknown function .
As we have previously reported (24), ABP, MLC, and 40P
COX ET AL .
￿
Cyclic Cytoskeletal Assembly
￿
1 1
Before activation 4,500
During initial activation* 12,600
At minimum of deaggregation 6,900
At maximum of reaggregation 18,000FIGURE 4
￿
Protein content of cytoskeletons during
cyclic activation . Platelet cytoskeletal core and su-
pernatant fractions were prepared, electrophoresed
on 6 to 17.5% polyacrylamide gradient SIDS slab
gels, and stained with Coomassie Blue as described
in Materials and Methods. Shown on the gel arethe
cytoskeletal core and supernatant fractions, respec-
tively, for unactivated washed platelets (lanes I and
2) ; arachidonic acid-activated platelets (lanes 3and
4) ; activated platelets after PGI2-reversal (lanes 5
and 6), and subsequent reactivation with epineph-
rine and arachidonic acid (lanes 7and 8). Molecular
weights (x 10-3 ) of standards are shown on the left .
Indicatedon the right margin are bands correspond-
ing to actin-binding protein (ABP), 200,000-dalton
heavy chain of myosin (MHC), a platelet alpha-
actinin-like protein (a-A), and actin .
TABLE II
MonomericActin Content in Whole Platelet Lysates andActin
Content in Isolated Cytoskeletal Cores during Cyclic Activation
' Percentages (of total platelet actin) were calculated by dividing the
DNAasel-inhibitory units in lysates by the inhibitory units in these same
lysates, but afterdepolymerization with 0.75Mguanidine-HCI as described
in Materials and Methods . These values are averages from three assays and
the standard error of the mean was 6%.
' Percentages (oftotal platelet actin) were calculated by dividing theDNAase-
I-inhibitory units in isolated cytoskeletal cores after depolymerization with
guanidine-HCI by the inhibitory units present in a total platelet lysate after
guanidine depolymerization . The standard error of the mean for these
sampleswas 9% . These cytoskeletal core samples were taken as duplicates
to the cytoskeletal cores shown in Fig . 2 .
were rapidly phosphorylated after AA activation, as shown in
Fig . 4, with the peak of 12P-labeling between 30 and 60 s .
Following this peak labeling, an aggregation-dependent de-
phosphorylation was observed that reduced the 32P-labeling
ofABP and MLC to basal levels by 5 min after AA addition .
The '2P-labeling of40P typically falls off at a slower rate with
-40-50% levels remaining after 10 min (full dephosphoryl-
ation time courses were shown previously (7, 25)).
Also shown in Fig. 5 is the effect on the phosphorylation
of ABP, MLC, and 40P ofPG12-induced reversal of platelet
activation . Accelerated loss of 32P from MLC was observed,
so that it was reduced below basal levels within 30 s of PG12
addition . The 40P labeling also showed a dramatic decrease
in ;IP-labeling falling to basal levels by 3 min after PG12
addition . In contrast, 12P-labeling ofABP increased after-PGI2
addition to levels above the initial activation peak response .
Upon reactivation of the platelets by epinephrine and AA,
MLC and 40P bands again showed increased 12P-labeling,
returning to peak levels obtained during the initial phospho-
rylation response. ABP that was already heavily labeled after
2
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PG12 introduction showed an additional modest increase
upon reactivation .
A somewhat inverse response was observed for a 24,000-
dalton band (24P) when compared to MLC and 40P phos-
phorylation over these time courses (Fig . 5) . The 32P-labeling
of 24P increased 1 .5-fold upon AA activation and showed a
further twofold increase after addition of PGI z opposite to the
rapid decline in MLC and 40P phosphorylation. The reacti-
vation by epinephrine and AA led to a decline of the 32P-
labeling of 24P back to levels observed before PG1 2 addition
but not to preactivation, basal levels. Greater than twofold
increases in 3-P-labeling of a 22,000-dalton protein (22P) was
also observed after PG12 addition, but, in contrast to 24P, no
reduction in 12P-labeling of this band was observed after
reactivation (data not shown) .
The phosphorylation patterns in Fig . 5 suggested that PG12
caused the dephosphorylation of40P andMLC but stimulated
phosphorylation ofABP . These conclusions were obscured by
the aggregation-induced dephosphorylation . For this reason,
the experiments were repeated in the presence ofEGTA which
prevents aggregation and thereby aggregation-initiated de-
phosphorylation . Fig . 6 shows the phosphorylation of 40P
and MLC induced by AA and reversed byPGIzin the absence
of aggregation . Clearly, PG1 2 leads to the dephosphorylation
of these two proteins . During the course of this study, Fein-
stein et al . (26) reported that prostaglandin D2 (PGD2) plus
theophylline and forskolin, both ofwhich cause elevated levels
of cAMP in platelets, reversed the phosphorylation of these
two proteins as well as core assembly induced by thrombin in
the presence ofEGTA .
Those proteins phosphorylated on addition of agents that
raise cAMP levels have been previously reported but the
molecular-weight range did not include ABP. Fig. 7 shows
the radioautogram of the SDS PAGE gel as well as quantifi-
cation ofthe time course ofphosphorylation induced by PG1 2 .
Not only was phosphorylation of 22P and 24P stimulated but
so wasABP phosphorylation to an extent similar to that seen
during activation (Fig . 5) . Included in this figure is one sample
where the phosphorylation induced by dibutyryl CAMP can
be compared with that induced by PG1 2 . Like PGI2, 2 mm
dibutyryl cAMP reversed aggregation; however, the disaggre-
Monomeric actin
content in
platelet lysates
Actin content
in isolated
cytoskeletal cores
Control 68 11
AA-activated 25 78
PG 12-reversed 62 5
Epinephrine-AA reactivated 32 71gated platelets were not reaggregated upon addition of epi-
nephrine plus AA (data not shown). ABP was phosphorylated
when dibutyryl CAMP was included, an observation that
suggests that PG12 stimulation of the phosphorylation of this
protein is also mediated through CAMP. Such phosphoryla-
tion of ABP by cAMP-dependent protein kinases in vitro has
been reported by Davies et al. (25).
DISCUSSION
The results presented here reveal that the interaction of
myosin and ABP with filamentous actin and the polymeri-
FIGURE 5 Platelet protein phos-
phorylation during cyclic activation.
During the time course, each of the
following reagents was added: 10
AM arachidonic acid (AA) to initiate
activation, 20 ng/ml PG12 to reverse
activation, and a combination of 30
AM epinephrine (Epi) plus 10 AM AA
for reactivation (additions indicated
by arrows). At each indicated time
point, aliquots oftotal platelets were
removed and immediately dena-
tured, and later these samples were
resolved by SDS PAGE as described
in Materials and Methods. The ra-
dioactivity was measured for the fol-
lowing platelet polypeptides: MLC
(E), 24P (p), and ABP (*) . 40P (9) is
plotted on a fourth scale, i .e., 1,000
cpm is plotted as 250 cpm.
FIGURE 6
￿
Reversal by PG12 of 40P
and myosin light chain phosphoryl-
ation in the absence of aggregation.
Duplicate samples of 12P-labeled
platelets were activated at zero time
with 10 Am arachidonic acid in the
presence of 2 mM EGTA to prevent
aggregation . After 2 min, 20 ng/ml
PG12 was added to the one sample
(closed symbols) while the other
sample served as an activation con-
trol. To the sample that received
PGIz, a combination of 30 AM epi-
nephrine and 10 AM AA was added
at 7 min. At each indicated time
point, aliquots oftotal platelets were
removed, immediately denatured,
and later resolved by SDS PAGE as
described in Materials and Meth-
ods. The radioactivity wasmeasured
for the following platelet peptides:
control activated, MLC (O) and 40P
(p), and activated-PGIz reversed at
2 min MLC (N) and 40P (9). As in
Fig. 5, the 40P radioactivity is plot-
ted on a fourth scale.
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zation of actin caused by platelet activation are completely
reversed by agents elevating platelet cAMP levels. In the case
of PG12 reversal of AA activation, the platelets remained
completelyfunctional and could be completelyreactivated by
treatment with epinephrine followed by exposure to AA. The
relief of PG12 inhibition correlates with reduction in CAMP
levels by epinephrine as established in previous studies (13).
Cytoskeletal disassembly, as well as the rapid MLC and 40P
dephosphorylation induced by PG12, correlatedwith increased
phosphorylation of 24P and 22P. During the reactivation by
epinephrine and AA, only the phosphorylation of 24P was
reduced to levels observed before PG12 addition.
COX ET AL.
￿
Cyclic Cytoskeletal Assembly
￿
1 3FIGURE 7
￿
Platelet protein phosphorylation induced by PG12 in the
absence of platelet activation . Aliquots were removed at the indi-
cated times and processed as described in Fig. 5 . The parts of the
figure are designated as A, radioautogram of total platelet proteins
during 20 ng/ml PG12 treatment taken at the indicated times above
the lanes ; B, radioautogram of total platelet proteins treated for 15
min with 2 mM dibutyryl cyclic AMP; and C, quantification of the
radioactivity during PG12 treatment in the following peptides : ABP
(*), 24P (/), and 22P (0) .
The apparent opposite response of ABP phosphorylation
which increased after PG12 addition and cytoskeletal disas-
sembly was explained by examining the effects of PG12 and
dibutyryl cAMP on unactivated platelets. Increased phospho-
rylation levels in ABP by these reagents, equal to those seen
upon platelet activation, certainly obscure whether dephos-
phorylation occurs during PG1 2 reversal ofplatelet activation.
Inhibition of platelet activation by cAMP has been sug-
gested to be the result of increased Ca++ sequestration (27)
or direct inactivation of the myosin kinase (28). Since both
of these inhibitory processes are suggested to be mediated by
CAMP-dependent phosphorylation, we looked for the in-
creased phosphorylation of any peptides correlating with
PGI2-induced reversal of platelet activation . As previously
reported by Fox et al . (27), we observed significant increases
4
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in 24P and 22P phosphorylation in response to addition of
PG12 or dibutyryl cAMP. However, only 24P-phosphorylation
levels showed any decline during epinephrine and AA reacti-
vation, whereas 22P levels actually increased slightly.
Conti and Adelstein (29) have suggested that cAMP-de-
pendent protein kinase phosphorylates myosin kinase at a site
that prevents the binding of calmodulin that is necessary for
myosin kinase activation . We were unable to identify signifi-
cant 12P-label increases by PG12 or dibutyrylcAMP treatment
in the 130,000-dalton region of the gels where the phospho-
rylated myosin kinase would be expected to migrate . How-
ever, in view of the relatively small amount ofthis enzyme in
the platelet and the presence ofmany phosphoproteins in this
region of the gels employed in our study, the possibility
remains that a cAMP-dependent phosphorylation of myosin
kinase is involved in PG12 reversal of activation .
A direct association of the glycoprotein IIb-III complex of
the platelet plasma membrane with the cytoskeletal cores of
activated platelets that have aggregated has been shown by
Phillips et al . (10) . This complex has been shown to be the
fibrinogen-binding site (11) . In this study we demonstrate that
increased fibrinogen binding correlates with cytoskeletal as-
sembly . Previously, Hawiger et al . (30) had demonstrated
fibrinogen binding that accompanies platelet activation and
aggregation induced by ADP or thrombin was blocked by
PG12 when added before ADP or thrombin . In this study,
expression of this binding site during platelet activation was
reversed by PG12 towards control levels, but was expressed
again upon reactivation with epinephrine and AA . These
results suggest reversible regulation of this binding site for
fibrinogen that mediates platelet aggregation . Furthermore,
the complex of glycoproteins Ilb-III is not modified in an
irreversible manner by PGI2-induced disaggregation but re-
mains readily activatable to support reaggregation .
The platelets contain a most dramatic display of the oppo-
sitional control of cellular reorganization whereby the cal-
cium-mediate processes of cellular activation are pitted
against the cAMP-mediate processes design to restore the
resting state . The ultrastructural changes are extensive as are
the assembly of the microtubular ring and the cytoskeleton.
These organizations and disorganizations, with the exception
of secretion, are reversible in both directions . While this
reversibility would be expected in smooth muscle cell con-
traction, where this oppositional control also exists, it is
remarkable that it is true in platelets where the changes are
so extensive, including external as well as internal processes.
This study was supported NHL Program Project grant HL 07207 and
by the Oklahoma Heart Association .
Receivedfor publication 10 December 1982, and in revisedform 31
May 1983.
REFERENCES
1 . Gerrard, J . M., and J . G. White. 1976 . The structure and function of platelets with
emphasis on their contractile nature. In Pathobiology Annual . H. L . lochain, editor.
Appleton-Centure-Crofts, New York . 31-58 .
2 . Carroll, R .C ., R . G. Butler, P . A . Moms, and J . M. Gerrard. 1982 . Separabl e assembly
of platelet pseudopodal and contractile cytoskeletons. Cell. 30:385-393 .
3 . Lebowitz,E .A.,andR . Cooke . 1978 . Contractile propertiesofactomyosin from human
blood platelets . J . Biol. Chem. 253:5443-5447 . .
4 . Daniel, J . L ., I . R. Molish, and H . Holmsen . 1981 . Myosin phosphorylation in intact
platelets.J . Biol . Chem . 256:7510-7514.
5 . Gerrard,J .M .,D.A. Peterson, andJ .G. White . 1981 .Calcium mobilization, In Platelets
in Biology and Pathology. J . L . Gordon, editor. Elsevier/North Holland, Amsterdam .
2:407-415 .
6 . Hathaway,D .R., andR . S . Adelstein . 1979 . Human platelet myosin light chain kinaserequires thecalcium bindingproteincalmodulin for activity. Proc. Natl. Acad. Sci. USA.
76:1653-1657.
7. Carroll, R. C., and J. M. Gerrard. 1982. Phosphorylatio n of platelet actin-binding
protein during platelet activation. Blood. 59:466-471.
8. Lyons, R. M., N. Stanford, and P. W. Majerus. 1975. Thrombin-induced protein
phosphorylation in human platelets. J. Clin. Invest. 56:924-936.
9. Lyons, R. M., and R. M. Atherton. 1979. Characterization of a platelet protein
phosphorylated during the thrombin induced release reaction. Biochemistry. 18:544-
552.
10. Phillips, D. R., L. K. Jennings, H. H. Edwards. 1980. Identification of membrane
proteins mediating the interaction ofhuman platelets. J. Cell Biol. 86:77-86.
11. Bennett,J. S., G. Vilaire, and D. B. Cines. 1982. Identification ofthe fibrinogen receptor
on human platelets by photoafnity labeling. J. Biol. Chem. 257:8049-8054.
12. Mustard, J. F., D. W. Perry, R. L. Kinlough-Rathbone, and M. A. Packham. 1975.
Factor s responsible forADP-inducedreleasereaction ofhuman platelets.Am. J. Physiol.
228:1757-1765.
13. Rao, G. H. R., K. R. Reddy, and J. G. White. 1980. The influence of epinephrine on
prostacyclin (PG12) induced dissociation of ADP aggregated platelets . Prostaglandins.
4:385-397.
14. Bolton, A. E., and W. M. Hunter. 1973. The labelling of proteins to high specific
radioactivities by conjugation to a 1231-containing acylating agent. Biochem. J 133:529-
539.
15. Studier, F. W. 1973. Analysisofbacteriophage Tr early RNAsand proteins on slabgels.
J. Mol. Biol. 79:237-248.
16. Mihalyi, E. 1968. Physicochemical studies ofbovine fibrinogen. IV. Ultraviolet absorp-
tion and its relation to the structure ofthe molecule. Biochemistry. 7:208-233.
17. Cox, A. C.,P. Inyangetor, C. T. Esmon, and B. N. White. 1979. The effectofaggregation
and release on platelet prothrombin-converting activity. Blood. 54:659-672.
18. Blikstad, L, F. Markey, L. Carlsson, T. Persson, and U. Lindberg. 1978. Selective assay
of monomeric and filamentous actin in cell extracts, using inhibition ofdeoxyribonu-
clease 1. Cell. 15:935-943.
19. Carlsson, L., F. Markey,1. Blikstad, T. Persson, and U. Lindberg. 1979. Reorganization
of actin in platelets stimulated by thrombin as measured by the DNase I inhibition
assay. Proc. Nail. Acad. Sci. USA. 76:6376-6380.
20. White, J. G. 1968. Fine structural alterations induced in platelets by adenosine diphos-
phate. Blood. 31 :604-622.
21. White,J. G.. and W. Krivit. 1967. An ultrastructural basis for theshapechangesinduced
in platelets by chilling. Blood. 30:625-635.
22. Gerrard, J. M., D. R. Phillips, G. H. R. Rao, E. F. Plow, D. A. Walz, R. Ross, L. A.
Harker. and J. G. White. 1980. Biochemical studies of two patients with gray platelet
syndrome. J. Clin. Invest. 66:102-109.
23. Peerschke, E. 1., M. B. Zucker, R. A. Grant, J. 1. Egan, and M. M. Johnson. 1980.
Correlation between fibrinogen binding to human platelets and platelet aggregability.
Blood. 55:841-847.
24. Gerrard, J. M., and R. C. Carroll. 1981. Stimulation ofplatelet protein phosphorylation
by arachidonic acid and endoperoxideanalogs. Proviaglandins. 22:81-94.
25. Davies, P. J. A., D. Wallach, M. C. Willingham, 1. Paston, M. Yamaguchi, and R. M.
Robson. 1978. Filamin-actin interactions. Dissociation ofbinding from gelatin by Ca=*-
activated proteolysis. J. Biol. Chem. 253:4036-4042.
26. Feinstein, M. B.,J. J. Egan,and E. E. Opas. 1983. Reversalofthrombin-induced myosin
phosphorylation and the assembly of cytoskeletal structures in platelets by adenylate
cyclase stimulants Prostaglandin D2 and forskolin. J. Biol. Chem. 258:1260-1267.
27. Fox, J. E. B., A. K. Say, and R. J. Haslam. 1979. Subcellular distribution ofthedifferent
platelet proteins phosphorylated on exposure ofintact platelets to ionophore A23187 or
prostaglandin E,. Biochem. J. 184:651-661.
28. Hathaway, D. R., C. R. Eaton, and R. S. Adelstein . 1980. Regulation ofhuman platelet
myosin kinase by calcium-calmodulin andcyclic-AMP. In The Regulation ofCoagula-
tion. K. G. Mann, F. B. Taylor, Jr., editors. Elsevier/North Holland, New York. 271-
276.
29. Conti, M. A.. and R. S. Adelstein . 1981. The relationship between calmodulin binding
and phosphorylation of smooth muscle myosin kinase by the catalytic subunit of3':5'
cAMP-dependent protein kinase. J. Biol. Chem. 256:3178-3181 .
30. Hawiger, J., S. Parkinson, and S. Timmons. 1980. Prostacyclin inhibits mobilization of
fibrinogen bindingsites on human ADPand thrombin-treated platelets. Nature(Land.).
283:195-197.
COX ET AL .
￿
Cyclic Cytoskeletal Assembly
￿
1 J 5